EP3579812A1

EP3579812A1 - Cosmetic preparation containing soda-lime-borosilicate glass beads

Info

Publication number: EP3579812A1
Application number: EP18702662.0A
Authority: EP
Inventors: Birgit Heitmann; David SCHLENKER; Andreas Bleckmann
Original assignee: Beiersdorf AG
Current assignee: Beiersdorf AG
Priority date: 2017-02-07
Filing date: 2018-01-30
Publication date: 2019-12-18
Also published as: WO2018145946A1; EP3695826A1; DE102017201869A1; US10952935B2; US20200009024A1

Abstract

The invention relates to a cosmetic preparation which contains at least one oil phase and soda-lime-borosilicate glass beads.

Description

description

Cosmetic preparation containing soda lime borosilicate glass beads The present invention relates to a cosmetic preparation containing at least one oil phase and soda lime borosilicate glass beads.

The desire to look beautiful and attractive is inherently rooted in man. Even though the ideal of beauty has undergone changes over time, the pursuit of an impeccable appearance has always been the goal of man. An essential part of a beautiful and attractive appearance is the condition and appearance of the skin.

For the skin to fulfill its biological functions to the full extent, it needs regular cleaning and care. Cleansing of the skin serves to remove dirt, sweat and remnants of dead skin particles, which form an ideal breeding ground for pathogens and parasites of all kinds. Skin cleansing is usually carried out with the aid of surface-active preparations (soaps, surfactants, more rarely alcoholic preparations) which are in the form of foam-forming gels or solids (soap bars) and are rinsed off with water after application to the skin.

Skin care products, usually creams, ointments or lotions, are mostly used to moisturize and moisturize the skin. Often they are added to active ingredients that the skin

regenerate and, for example, prevent and reduce their premature aging (e.g., the appearance of wrinkles, wrinkles).

The variety of commercially available skin care products, including the

Sunscreen, but must not hide the fact that this

Preparations of the prior art have a number of disadvantages. Cosmetic skin care products, even those based on an ethanolic solution, usually contain oil components and other more or less sticky ingredients that cause dust-like, fine-grained particles to adhere more to the skin. This problem is especially troublesome with sunscreens used by consumers on the Beach to be applied. The problem of the so-called sand adhesion to sunscreens has been repeatedly described in the literature. However, the problem also occurs with other cosmetic products and other everyday situations, for example with day creams or after creams in connection with house dust or pollen.

It was therefore the object of the present invention to reduce the particle adhesion on the skin caused by the cosmetic preparation and in particular the sand adhesion on the skin caused by the cosmetics (in particular sunscreens).

A possible according to the prior art solution of the problem is to incorporate so-called powder raw materials from solid at room temperature plastic particles in the preparations. These room temperature solid plastic particles are made of polyethylene, polypropylene, polymethylmethacrylate or nylon. This is also the definition according to the invention for these substances. A disadvantage of this prior art is the fact that the use of these substances in connection with the so-called 'microplastic' discussion, i. the discussion on the use of plastic particles in cosmetics and their fate after cosmetic application in the environment, is increasingly regarded as undesirable. Whether and, if so, to what extent this discussion is justified, can be discussed in this context

Revelation left undecided. However, the fact is that consumers are increasingly interested in cosmetic products that no longer have these ingredients.

It was therefore the object of the present invention to reduce the particle adhesion on the skin caused by the cosmetic preparation and in particular the sand adhesion on the skin caused by the cosmetics (in particular sunscreens) without having plastic particles which are solid for the room temperature, ie. polyethylene,

Polypropylene, polymethylmethacrylate or nylon. Surprisingly, these objects are achieved by a cosmetic preparation containing at least one oil phase and glass beads of soda lime borosilicate.

It is inventively preferred if the preparation is free of solid at room temperature plastic particles.

Although the prior art knows glass beads for cosmetic preparations, for example from alkali-lime glass (eg from GP Cosmetics) or magnesium silicate (eg Covabead Crystal from Sensient Cosmetic Technologies). However, these have the disadvantage of emulsions, ie the most common cosmetic preparation form to discoloration of the preparation to lead. There are also stability problems with silica-based encapsulated UV filters (eg Eusolex UV-Pearls from Merck). However, it was the object of the present invention to develop stable (in particular color-stable) preparations, in particular emulsions (and here O / W emulsions).

It is inventively advantageous if the glass beads according to the invention a

Have particle diameter of 5 to 120 μηη. The particle size (particle diameter) of the glass beads according to the invention can be determined in accordance with customary standards, for example by sieving. Of course, it is known to the person skilled in the art that the particle size (grain size) is always subject to a certain size distribution. The size indication therefore means that no larger

Glass beads are used as those with a particle diameter of 120 μηη and it is not critical if small amounts of smaller particles than impurities

(For example, caused by "glass breakage") are included in the preparation.

It is inventively advantageous if the glass beads according to the invention are hollow. Embodiments of the present invention which are advantageous according to the invention are characterized in that the density of the glass beads is 0.1 to 1.0 g / cubic centimeter. In this case, a density of 0.13 to 0.63 is preferred according to the invention.

Moreover, it is advantageous according to the invention if the glass beads have an oil absorption of 0.2 to 0.6 grams of oil per cubic centimeter of glass beads, measured according to ASTM D281-95. In this case, an oil absorption of 0.3 to 0.5 grams of oil per cubic centimeter

Glass beads, measured according to ASTM D281-95, according to the invention preferably.

It is advantageous for the purposes of the present invention if the glass beads have a pH of 9 to 10, measured according to ASTM D3100-1982.

It is inventively advantageous if the glass beads have a softening temperature of 550 to 650 ° C. The softening is after 2 hours storage at the

corresponding temperature determined. Preferred according to the invention is a

Softening temperature of 590 to 610 ° C, ideally it is 600 ° C. Also according to the invention is the use of the glass beads according to the invention for reducing the adhesion of sand, pollen or dust on the skin caused by the

Treatment of the skin with cosmetics, especially sunscreen is caused. It is inventively advantageous if the preparation contains the glass beads in an amount of 0, 1 to 10% by weight, based on the total weight of the preparation. In this case, a content of 1 to 6% by weight, based on the total weight of the preparation,

preferred according to the invention.

Embodiments of the present invention which are advantageous according to the invention are characterized in that the oil phase of the preparation comprises one or more oil components selected from the group consisting of the compounds diisopropyl adipate, caprylic / capric triglyceride (INCI Caprylic / Capric Triglycerides), isopropyl palmitate, dimethicone, cyclomethicone, octyldodecanol, ethylhexyl cocoate, myristyl myristate, Hydrogenated cocos glycerides (INCI Hydrogenated Coco-Glycerides), dicaprylyl carbonate, C18-38 alkylhydroxystearoryl stearate (INCI C18-38 alkyl hydroxystearoyl stearates), di-n-butyl adipate, butylene glycol dicaprylate / dicaprate (INCI Butylene Glycol Dicaprylate / Dicaprate), C12-15 alkyl benzoate (INCI C12-15 alkyl benzoate), 2-phenylethyl benzoate (INCI phenethyl benzoate), di C12-13 alkyl tateate (INCI di-C12-13 alkyl tatrate), butylene glycol cocoate (INCI: butylene glycol cocoate), dicaprylyl ether,

Isodecyl neopentanoate, tridecyltrimellate, isopropyl stearate, C12.13 alkyl lactate, 2-propylheptyo-octanoate, isopropyl lauryl sarcosinate.

The oil components preferred according to the invention are diisopropyl adipate,

Caprylic / Capric Acid Triglyceride (INCI Caprylic / Capric Triglycerides), Octyldodecanol,

Ethylhexyl cocoate, myristyl myristate, hydrogenated cocos glycerides (INCI Hydrogenated Coco-Glycerides), di-n-butyl adipate, butylene glycol dicaprylate / dicaprate (INCI Butylene Glycol

Dicaprylates / dicaprate), C12-15 alkyl benzoate (INCI C12-15 alkyl benzoate), 2-phenylethyl benzoate (INCI phenethyl benzoate).

It is inventively advantageous if the total amount of these invention advantageous ol components from 1 to weight 20%, based on the total weight of the preparation, wherein the preferred amount range of 2 to weight 15%, based on the total weight of the preparation.

It is advantageous according to the invention if the preparation according to the invention contains one or more UV filters selected from the group of the compounds phenylene-1,4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid salts ; 2-phenylbenzimidazole-5-sulfonic acid salts; 1,4-di (2-oxo-10-sulfo-3-bomylidenemethyl) benzene and its salts; 4- (2-oxo-3-bomylidenemethyl) benzene sulfonic acid salts; 2-methyl-5- (2-oxo-3-bornylidenemethyl) sulfonic acid salts; 2- (2H-benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1,3,3,3-tetramethyl-1 - [(trimethylsilyl) oxy] disiloxanyl] propyl] - phenol; 3- (4-methylbenzylidene) camphor; 3-benzylidenecamphor; ethylhexyl salicylate; Terephthalidendicamphersulfonsäure; 4- (dimethylamino) benzoic acid (2-ethylhexyl) ester; 4- (dimethylamino) benzoic acid amyl ester; 4-Methoxybenzalmalon-säuredi (2-ethylhexyl) ester; 4-methoxycinnamic acid (2-ethylhexyl) ester; Isoamyl 4-methoxycinnamate; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone;2,2'-dihydroxy-4-methoxybenzophenone; Hexyl 2- (4'-diethylamino-2'-hydroxybenzoyl) benzoate, 4- (tert-butyl) -4'-methoxydibenzoylmethane;homomenthyl; 2-ethylhexyl 2-hydroxybenzoate; 2-ethylhexyl-2-cyano-3,3-diphenylacrylate; dimethicodiethylbenzalmalonate; 2-ethylhexyl 2-cyano

3.3-diphenylacrylate; 3- (4- (2,2-bisethoxycarbonylvinyl) phenoxy) propenyl) methoxysiloxane / dimethylsiloxane copolymer; Dioctylbutylamidotriazone (INCI: diethylhexyl-butamidotriazone);

2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) -imino] -6- (2-ethylhexyl) -imino-1,3,5-tri with (CAS No. 288254 -16-0); 4,4 ', 4 "- (1,3,5-triazine-2,4,6-triyltriimino) tris-benzoic acid tris (2-ethylhexyl ester) (also: 2,4,6-tris [anilino] (p-carbo-2'-ethyl-1'-hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone); 2,4-bis - {[4- (2-ethylhexyloxy) -2 -hydroxy] -phenyl} -6- (4-methoxyphenyl) -1,3,5-triazine; 4-dicyanomethylene-2,6-dimethyl-1,4-dihydropyridine N- (ethyloxy sulfate ester salts), titanium dioxide; zinc oxide.

It is inventively preferred when the preparation of the invention is free of 2-ethylhexyl-2-cyano-3,3-diphenyl, 2-hydroxy-4-methoxybenzophenone, 4-methoxycinnamate (2-ethylhexyl) ester 4-Methoxycinntsäureisoamylester and / or 3- (4-methylbenzylidene) camphor. Particular preference should be given to the use of 4-methoxycinnamic acid (2-ethylhexyl) ester, 4-methoxycinnamic acid isoamyl ester 3- (4-methylbenzylidene) camphor and 2-hydroxy-4-methoxybenzophenone.

On the other hand, the use of 4- (tert-butyl) -4'-methoxydibenzoylmethane,; Hexyl 2- (4'-diethylamino-2'-hydroxybenzoyl) benzoate (INCI: diethylamino hydroxybenzoyl hexyl benzoate), 2-phenylbenzimidazole-5-sulfonic acid salt, ethylhexyl salicylate; Dioctylbutylamidotriazone (INCI: diethylhexylbutamidotriazone), 4,4 '- (1,3,5-triazine-2,4,6-triyltriimino) tris-benzoic acid tris (2-ethylhexyl ester) (also: 2, 4,6-tris [anilino- (p-carbo-2'-ethyl-1 '-hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone) and 2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine particularly preferred according to the invention, these UV filters can be used individually or as a mixture.

Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation is in the form of an emulsion. In this case, C7W emulsions (oil-in-water emulsions) are preferred according to the invention. In such a case, it is particularly advantageous according to the invention if the preparation is in the form of an O / W emulsion emulsified with one or more emulsifiers selected from the group of the compounds glyceryl stearate citrate, glyceryl stearate (self-emulsifying), stearic acid, stearate salts , Polyglyceryl-3-methylglycose distearate, sodium stearoylglutamate, sodium cetearylsulfate, potassium cetyl phosphate, cetearylsulfosuccinate, polyglyceryl-10 stearate, polyglyceryl-10 laurate, polyglyceryl-10 caprate. These emulsifiers are usually used in a total concentration of 0.5 to 10% by weight, based on the total weight of the preparation. It is advantageous for the purposes of the present invention if the preparation comprises one or more alcohols selected from the group of the compounds ethanol, glycerol, ethylhexylglycerol, phenoxyethanol, polyglyceryl-2-caprate, propylene glycol, butylene glycol, 2-methylpropane-1, 3-diol, 1 , 2-pentanediol, 1, 2-hexanediol, 1, 2-octanediol, 1, 2-decanediol.

These emulsifiers can be used in a total concentration of 0.2 to 80% by weight, based on the total weight of the preparation.

Embodiments of the present invention that are advantageous according to the invention are characterized in that the preparation comprises one or more compounds selected from the group of the compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, isoflavonoids, flavonoids, Creatine, creatinine, taurine, β-alanine, panthenol, polydocanol, tocopheryl acetate, dihydroxyacetone, glycerylglycose, (2-hydroxyethyl) urea, vitamin E or vitamin E acetate, hyaluronic acid and / or its sodium salts, menthol, glycyrrhetinic acid and / or licochalcone A. contains. Not least, it is according to the invention advantageous if the preparation one or more polymers selected from the group of compounds xantham gum, tapioca starch,

Hydroxyethyl cellulose, carbomer, acrylate / C 10-30 alkyl acrylate,

Vinylpyrrolidone / hexadecene copolymer. In addition, the cosmetic preparation may be composed as a conventional cosmetic for such cases and contain the corresponding known ingredients. Comparative test

The following formulations were prepared and the sanding with the help of the following

Method determined.

In vitro sand adhesion

50 mg of the test emulsion was applied to PMMA Schönberg plates (5.0 x 5.0 cm) and evenly distributed on the plate with a fingerstall. Subsequently, the applied example formulation is dried for 15 min at room temperature. Thereafter, the weight of the dried plates was determined with an analytical balance. Subsequently, the plates were poured over with fine sea sand (1.0771 1.1000 sea sand reinst, Merck KGaA) in excess. By sliding once the plates on a designated

Slip device (see below) was removed loosely adhering sand with reproducible, uniform force.

The adherent sand remaining on the plate was then determined by weighing. The sand adhesion can be determined with the following equation:

Δ adhesion) [mg] = m (plate with sand) [mg] - m creamed plate) [mg] The slip device is a triangular construction in which the width of the chute is 5 cm. The slip device is a construction constructed in the shape of a right-angled triangle in which the width of the slide is 5 cm. The Ankathete the right triangle (= standing surface of the slide) has a length of 13.5 cm, the Gegenkathete (= drop height) has a length of 49 cm. The hypotenuse on which the slip takes place and the footprint enclose an angle of 275 °.

The experiments were repeated 10 times per formulation and the corresponding mean value was formed.

Individual data sand adhesion: w plate w plate + sand w sand MediumStandard¬

Specimen in g in g absolute in g value deviation

SWEAT: 249 a-15 7,292 7.35 0.058

SWEAT: 249 b-15 7,297 7,423 0.126

SWAET: 249 c-15 7,299 7,429 0.13

SWAET: 249 d-15 7.27 7,376 0.106

SWEAT: 249 e-15 7.31 1 7.395 0.084

SWEAT: 249 f-15 7,279 7,385 0.106

SWEAT: 249 g-15 7.169 7.287 0.1 18

SWEAT: 249 h-15 7,301 7.35 0.049

SWEAT: 249 i-15 7,305 7,434 0.129

SWEAT: 249 j-15 7.29 7,396 0.106 0.101 0.029

SWEAT: 260 a-15 7,292 7,294 0.002

SWEAT: 260 b-15 7.31 1 7.314 0.003

SWAET: 260 c-15 7.216 7.218 0.002

SWAET: 260 e-15 7.152 7.154 0.002

SWEAT: 260 e-15 7,106 7.1 1 0.004

SWEAT: 260 f-15 7.285 7.287 0.002

SWEAT: 260 g-15 7.172 7.179 0.007

SWEAT: 260 h-15 7.166 7.17 0.004

SWEAT: 260 i-15 7,199 7,207 0.008

SWEAT: 260 j-15 7,323 7,329 0.006 0.004 0.002

SWEAT: 261 a-15 7,264 7,301 0.037

SWEAT: 261 b-15 7,249 7,252 0.003

SWAET: 261 c-15 7,313 7,322 0.009 0

SWAET: 261 d-15 7,323 7,327 0.004

SWEAT: 261 e-15 7,298 7,318 0.02

SWEAT: 261 f-15 7,307 7,317 0.01

SWEAT: 261 g-15 7.325 7.332 0.007

SWEAT: 261 h-15 7,291 7,299 0.008

SWEAT: 261 i-15 7,291 7,295 0.004

SWEAT: 261 j-15 7.325 7.331 0.006 0.01 1 0.010 adhering sand in standard

Sample mg / cm ² (15 minutes) deviation

SWEAT: 249 N-free 4.0 1, 16

SWEAT: 260 N-free + 5% 3M Glass Bubbles K15 0.2 0.08

SWEAT: 261 N-free + 5% 3M Glass Bubbles IM30K 0.4 0.4

Examples

The following examples are intended to illustrate the present invention without limiting it. Unless indicated otherwise, all amounts, proportions and percentages are based on the weight and the total amount or on the total weight of the preparations.

Trisodium EDTA 1 0.5 1 1 1 0.5 0.5 1 1 1

Homosalates 9 9 9 9,5 9 9 9 9 9

Octocrylene 9 9 9,5 8 8

Ethyl hexyl salicylates 4.5 4.75 4.75 4.75 4.75 4.75 4.75 4.75 4.75

butyl

Methoxy dibenzoylmethane 4.5 4.5 4.75 4.75 4.75 4.5 4.5 4.75 4.75

Titanium dioxide 3 6 1 3,5

Until Ethylhexyloxyphenol

Methoxyphenyl triazines 3 4 4 3,5 4 4 3,5 3 4

Ethylhexyl triazone 3 3 3 3 3

diethylamino

hydroxybenzoyl

Hexyl benzoates 8

Polysilicone-15 1

Phenylbenzimidazolesulphonic

Sulfonic Acid 1 1 1 1 1, 5 1, 5 1 ad ad ad ad ad ad ad ad

Aqua 100 100 100 100 100 100 100 100 100 100

Claims

claims

1 . Cosmetic preparation containing at least one oil phase and soda lime borosilicate glass beads.

2. Cosmetic preparation according to claim 1, characterized in that the

Preparation is free from solid at room temperature plastic particles.

3. Cosmetic preparation according to one of the preceding claims, characterized

characterized in that the glass beads have a particle diameter of 5 to 120 μηη.

4. Cosmetic preparation according to one of the preceding claims, characterized

characterized in that the glass beads are hollow.

5. Cosmetic preparation according to one of the preceding claims, characterized

in that the density of the glass beads is 0.1 to 1.0 g / cubic centimeter.

6. Cosmetic preparation according to one of the preceding claims, characterized

in that the glass beads have an oil absorption of from 0.2 to 0.6 grams of oil per cubic centimeter of glass beads, measured according to ASTM D281-95

7. Cosmetic preparation according to one of the preceding claims, characterized

characterized in that the glass beads have a pH of 9 to 10, measured according to ASTM D3100-1982.

8. Cosmetic preparation according to one of the preceding claims, characterized

characterized in that the glass beads have a softening temperature of 550 to 650 ° C.

9. Cosmetic preparation according to one of the preceding claims, characterized

in that the preparation contains the glass beads in an amount of 0.1 to 10% by weight, based on the total weight of the preparation.

10. Cosmetic preparation according to one of the preceding claims, characterized

in that the oil phase of the preparation contains one or more oil components selected from the group of compounds diisopropyl adipate, caprylic / capric triglyceride (INCI Caprylic / Capric Triglycerides), isopropyl palmitate, dimethicone, cyclomethicone, octyldodecanol, ethylhexyl cocoate, myristyl myristate, hydrogenated cocos glycerides (INCI Hydrogenated Coco-Glycerides), dicaprylyl carbonate, C18-38 alkylhydroxystearoryl stearate (INCI C18-38 alkyl hydroxystearoyl stearate), di-n-butyl adipate, butylene glycol dicaprylate / dicaprate (INCI Butylene Glycol

Dicaprylates / dicaprate), C12-15 alkyl benzoate (INCI C12-15 alkyl benzoate), 2-phenylethyl benzoate (INCI phenethyl benzoate), di C12-13 alkyl tate (INCI di-C12-13 alkyl tatrate), butylene glycol cocoate (INCI: butylene glycol cocoate ), Dicaprylyl ether, isodecyl neopentanoate, tridecyltrimellate, isopropyl stearate, C12.13 alkyl lactate, 2-propylheptyo-octanoate, isopropyl lauryl sarcosinate.

1 1. Cosmetic preparation according to one of the preceding claims, characterized in that the preparation contains one or more UV filters selected from the group of compounds phenylene-1,4-bis (2-benzimidazyl) -3,3'- 5,5'-tetrasulfonic acid salts; 2-phenylbenzimidazole-5-sulfonic acid salts; 1,4-di (2-oxo-10-sulfo-3-bomylidenemethyl) benzene and its salts; 4- (2-oxo-3-bomylidenemethyl) benzene sulfonic acid salts; 2-methyl-5- (2-oxo-3-bornylidenemethyl) sulfonic acid salts; 2- (2H-benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1,3,3,3-tetramethyl-1 - [(trimethylsilyl) oxy] disiloxanyl] propyl] -phenol; 3- (4-methylbenzylidene) camphor; 3-benzylidenecamphor;

ethylhexyl salicylate; Terephthalidendicamphersulfonsäure; 2-ethylhexyl 4- (dimethylamino) benzoate; 4- (dimethylamino) benzoic acid amyl ester; Di (2-ethylhexyl) -4-methoxybenzalmalonate; 2-ethylhexyl 4-methoxycinnamate; Isoamyl 4-methoxycinnamate; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone; 2,2'-dihydroxy-4-methoxybenzophenone; Hexyl 2- (4'-diethylamino-2'-hydroxybenzoyl) benzoate, 4- (tert-butyl) -4'-methoxydibenzoylmethane; homomenthyl; 2-ethylhexyl 2-hydroxybenzoate; 2-ethylhexyl-2-cyano-3,3-diphenylacrylate; dimethicodiethylbenzalmalonate; 2-ethylhexyl-2-cyano-3,3-diphenylacrylate; 3- (4- (2,2-bisethoxycarbonylvinyl) phenoxy) propenyl) methoxysiloxane / dimethylsiloxane copolymer; Dioctylbutylamidotriazone (INCI: diethylhexylbutamidotriazone); 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) -imino] -6- (2-ethylhexyl) -imino-1,3,5-triazine having the (CAS No 288254-16-0); 4,4 ', 4 "- (1,3,5-triazine-2,4,6-triyltriimino) tris-benzoic acid tris (2-ethylhexyl ester) (also: 2,4,6-tris [anilino] (p-carbo-2'-ethyl-1'-hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone); 2,4-bis - {[4- (2-ethylhexyloxy) -2 -hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine; 4-dicyanomethylene-2,6-dimethyl-1,4-dihydropyridine-N- (ethyloxy sulfate ester salts), titanium dioxide; zinc oxide.

12. Cosmetic preparation according to one of the preceding claims, characterized

characterized in that the preparation is in the form of an emulsion.

13. Cosmetic preparation according to one of the preceding claims, characterized

in that the preparation is in the form of an O / W emulsion which is emulsified with one or more emulsifiers selected from the group of the compounds glyceryl stearate citrate, glyceryl stearate (self-emulsifying),

Stearic acid, stearate salts, polyglyceryl-3-methylglycose distearate,

Sodium stearoyl glutamate, sodium cetearyl sulfate, potassium cetyl phosphate,

Cetearyl sulfosuccinate, polyglyceryl-10 stearate, polyglyceryl-10 laurate, polyglyceryl-10 caprate.

14. Cosmetic preparation according to one of the preceding claims, characterized

in that the preparation contains one or more alcohols selected from the group of the compounds ethanol, glycerol, ethylhexylglycerol, phenoxyethanol, Polyglyceryl-2 caprate, propylene glycol, butylene glycol, 2-methylpropane-1, 3-diol, 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-octanediol, 1, 2-decanediol.

15. Cosmetic preparation according to one of the preceding claims, characterized

denote that the preparation contains one or more compounds selected from the group of the compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, isoflavonoids, flavonoids, creatine, creatinine, taurine, ß- Alanine, panthenol, polydocanol, tocopheryl acetate, dihydroxyacetone, glycerylglycose, (2-hydroxyethyl) urea, vitamin E or vitamin E acetate,

Hyaluronic acid and / or their sodium salts, menthol, glycyrrhetinic acid and / or licochalcone A contains.

16. Cosmetic preparation according to one of the preceding claims, characterized

in that the preparation contains one or more polymers selected from the group of the compounds xantham gum, tapioca starch, hydroxyethyl cellulose, carbomer, acrylate / C 10-30 alkyl acrylate, vinylpyrrolidone / hexadecene copolymer.